iTeos Therapeutics (ITOS): An Example of Biotech Liquidations
LVS Advisory, a New York City-based full-service investment firm, recently released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Iteos Therapeutics Inc. (ITOS)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Almitas Capital Ron Mass | 0 | $0 | 0% | |
| 2. | Alyeska Investment Group Anand Parekh | 0 | $0 | 0% | |
| 3. | Sandia Investment Management Tim Sichler | 0 | $0 | 0% | |
| 4. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 5. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.00 | 3,300,000 | $26,400,000.00 | 10,688,978 | 2025-05-15 | Filing | |
| $7.41 | 1,658,978 | $12,285,561.58 | 7,388,978 | 2025-05-14 | Filing | |
| $7.73 | 5,000 | $38,635.00 | 65,429 | 2024-11-19 | Filing | |
| $8.37 | 5,000 | $41,850.00 | 19,429 | 2023-10-12 | Filing | |
| $32.85 | 20,000 | $656,980.00 | 3,192,058 | 2022-03-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.02 | 43,883 | $439,707.66 | 0 | 2025-06-10 | Filing | |
| $10.02 | 8,400 | $84,168.00 | 135,903 | 2025-06-10 | Filing | |
| $10.03 | 43,882 | $440,136.46 | 0 | 2025-06-09 | Filing | |
| $10.03 | 8,400 | $84,252.00 | 135,903 | 2025-06-09 | Filing | |
| $10.21 | 43,882 | $448,035.22 | 0 | 2025-06-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 217 | $2,508 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 5 most undervalued biotech stocks to buy according to hedge funds.
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds.
Hedge Fund and Insider Trading News: Christopher Hohn, Gramercy Funds Management, Citadel LLC, Starboard Value LP, WizardQuant, Momentum Global Investment Management, iTeos Therapeutics Inc (ITOS), and More
(Yicai Global) March 25 -- If the United States were to decouple from China, it would slow innovation, Ken Griffin, founder and chief executive of US financial firm Citadel LLC, said in a recent interview...
Is ITOS A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...
Hedge Fund Resource Center Billionaire Hedge Funds
